Schedule 13D ownership disclosure
ARS Pharmaceuticals Inc
Security class unavailable · CUSIP: 82835W108
Event date: 2023-09-21
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,459,678
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-103530
- Form type
- SC 13D
- Filer
- ARS Pharmaceuticals, Inc.
- CIK
- CIK 1671858
- Filed
- Sep 25, 2023
- Reporting period
- Sep 21, 2023
- Description
- Schedule 13D beneficial ownership